Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Drug Resistance

Free Subscription 02.11.2026 1 Antimicrob Agents Chemother 3 Clin Infect Dis 1 Infect Control Hosp Epidemiol 3 Int J Antimicrob Agents 2 J Antimicrob Chemother 1 J Clin Microbiol 2 J Infect Chemother 1 N Engl J Med 2 PLoS Med 3 PLoS One 1 Proc Natl Acad Sci U S A 1 Virology

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Antimicrob Agents Chemother

1. HTAIK K, Vodstrcil LA, Plummer EL, Matthews LG, et al
   Does pre-treatment with doxycycline improve the efficacy of combination minocycline and metronidazole for macrolide-resistant Mycoplasma genitalium infections?
   Antimicrob Agents Chemother. 2026 Oct 29:e0056026. doi: 10.1128/aac.00560.
   PubMed         Abstract available
   
   

   
   Clin Infect Dis

2. SHEETS A, Dennison J, Han JH, Watts S, et al
   Subgroup Analysis of Pooled Phase 3 Efficacy Data from Two Randomized Trials of Gepotidacin Versus Nitrofurantoin in Uncomplicated Urinary Tract Infections (EAGLE-2 and EAGLE-3) including Participants with Uropathogens Not-Susceptible to Nitrofurantoi
   Clin Infect Dis. 2026 Jul 8:ciag408. doi: 10.1093.
   PubMed         Abstract available
   
   
3. ROGG L, Nunez SA, Mingrone MV, Domingo P, et al
   Proof-of-Concept Phase 2a Trial of VH4524184 (VH-184), an Emerging Third-Generation Integrase Strand Transfer Inhibitor With an Enhanced Resistance Profile.
   Clin Infect Dis. 2026 Jun 12:ciag357. doi: 10.1093.
   PubMed         Abstract available
   
   
4. KRISHNASWAMI RK, Dubey DK, Sonawane RV, Potdar PR, et al
   Cefepime-Zidebactam for Infections Caused by Carbapenem-Resistant Gram-Negative Bacteria, Including Metallo-beta-Lactamase Producers: A Phase 2, Open-Label, Single-Arm, Multicenter Study.
   Clin Infect Dis. 2026 Oct 23:ciag665. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Infect Control Hosp Epidemiol

5. SINGH BK, Lutgring JD, Wolford H, Octaria R, et al
   Assessment of pathogen reduction strategies in reducing carbapenem-resistant Enterobacterales (CRE) transmission in acute-care hospitals: an agent-based model study.
   Infect Control Hosp Epidemiol. 2026 Oct 30:1-7. doi: 10.1017/ice.2026.10472.
   PubMed         Abstract available
   
   

   
   Int J Antimicrob Agents

6. LI R, He J, Song J, Zhu T, et al
   Plasma and Pulmonary Exposure of Eravacycline in a 73-Year-Old Patient with Carbapenem-Resistant Acinetobacter baumannii Pneumonia.
   Int J Antimicrob Agents. 2026 Oct 29:108056.
   PubMed         Abstract available
   
   
7. KILLOL AJ
   Comment on "Unveiling the Clonal Dynamics and Transmission Mechanism of Carbapenem-Resistant Klebsiella pneumoniae in the ICU Environment".
   Int J Antimicrob Agents. 2026 Oct 28:108049.
   PubMed        
   
   
8. WANG Z, Wei Q, An J, Xiang Y, et al
   Bacillus subtilis R-179 combined with Enterococcus faecium R-026 alleviate antibiotic-associated diarrhea by modulating gut microbiota and antibiotic resistance genes.
   Int J Antimicrob Agents. 2026 Oct 26:108041.
   PubMed         Abstract available
   
   

   
   J Antimicrob Chemother

9. PAN P, Mo C, Chen R, Liao Y, et al
   Evaluation of capsid inhibitor resistance profiles and HIV-1 subtype distribution via near-full-length genome NGS in ART-naive HIV-1 patients in Guangxi, China.
   J Antimicrob Chemother. 2026;81:dkag334.
   PubMed         Abstract available
   
   
10. SANTORO MM, Spalletta D, Spagnuolo V, Paletti C, et al
    Virological outcomes, resistance profile and viral evolution of lenacapavir-based regimens in heavily treatment-experienced people: data from the PRESTIGIO Registry.
    J Antimicrob Chemother. 2026;81:dkag335.
    PubMed         Abstract available
    
    

    
    J Clin Microbiol

11. HWANG H, Orth M, Jawahir S, Gross A, et al
    Whole genome-based characterization of virulence and antimicrobial resistance determinants in clinical Campylobacter jejuni isolates from Minnesota, 2018-2021.
    J Clin Microbiol. 2026 Oct 27:e0051426. doi: 10.1128/jcm.00514.
    PubMed         Abstract available
    
    

    
    J Infect Chemother

12. SETO J, Wada T, Murase Y, Mitarai S, et al
    A hypothesis-generating study of collateral reactivation: a reanalysis of Mycobacterium tuberculosis genomes from 119 recurrent tuberculosis cases.
    J Infect Chemother. 2026;32:103109.
    PubMed         Abstract available
    
    
13. NAKAMURA H, Imuta N, Ooka T, Kawamura H, et al
    Phylogenetic analysis and plasma resistance of blood-derived Escherichia coli isolates that cause bacteremia at a tertiary care hospital in Japan.
    J Infect Chemother. 2026;32:103091.
    PubMed         Abstract available
    
    

    
    N Engl J Med

14. TAMMA PD
    Gram-Negative Bacterial Resistance.
    N Engl J Med. 2026;395:1728-1743.
    PubMed         Abstract available
    
    

    
    PLoS Med

15. SINGER BJ, Gleason A, Impalli I, Nagorsen MD, et al
    Burden of bacterial antimicrobial resistance associated with modifiable human antibiotic consumption: An observational study.
    PLoS Med. 2026;23:e1005140.
    PubMed         Abstract available
    
    
16. GRAD YH, Mittelstaedt R, Peters RPH
    How do we monitor doxy-PEP impact and when should we consider revisiting guidelines?
    PLoS Med. 2026;23:e1005276.
    PubMed         Abstract available
    
    

    
    PLoS One

17. UDDIN MH, Dutta P, Islam M, Rahman MK, et al
    Ecology and epidemiology of multidrug resistance Salmonella in fruit Bats and shared water sources in Bangladesh.
    PLoS One. 2026;21:e0361701.
    PubMed         Abstract available
    
    
18. BERHE B, Negash H, Abadi T, Belay G, et al
    Schistosoma-Salmonella co-infection in Africa: Epidemiology, biological mechanisms, and antimicrobial resistance: A systematic review and meta analysis.
    PLoS One. 2026;21:e0359975.
    PubMed         Abstract available
    
    
19. ELGAMMAL Y, Salama EA, Alkashef NM, Lawrence CB, et al
    Repurposing the phospholipase A2 inhibitor, darapladib, to combat multidrug-resistant fungal pathogens, including Candida auris.
    PLoS One. 2026;21:e0361366.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

20. YADAV M, C A NF, Mandal D, Shukla J, et al
    A voltage-gated porin PPE1 regulates secretion and drug resistance in Mycobacterium tuberculosis.
    Proc Natl Acad Sci U S A. 2026;123:e2602335123.
    PubMed         Abstract available
    
    

    
    Virology

21. ULUCAM ATAY G, Alpay Karaoglu S, Bozdeveci A, Suyabatmaz S, et al
    Genomic and biological characterization of PhiAB114, a temperate siphovirus infecting colistin- and carbapenem-resistant Acinetobacter baumannii.
    Virology. 2026;625:111109.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Drug Resistance is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum